AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in Percent.
The item "Funds-From-Operation-To-Total-Debt" stands at 48.40 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Funds From Operation To Total Debt" stands at 48.40 Percent. This represents an increase of 5.98 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.19 percentage points compared to the value the year prior.
The 1 year change in percentage points is 11.19.
The 3 year change in percentage points is 17.56.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Funds From Operation To Total Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Funds From Operation To Total Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Funds From Operation To Total Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Funds From Operation To Total Debt | 317,433,206,677.55 |
![]() | Novartis AG - Funds From Operation To Total Debt | 255,096,620,580.91 |